Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer

NCT00761345 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Carcinoma Non-resectable
Metastatic Pancreatic Cancer

Interventions

DRUG: gemcitabine
DRUG: Erlotinib
RADIATION: low dose fractionated radiotherapy

Sponsor

Fox Chase Cancer Center